• News and Events
EKF Diagnostics logo
  • Point of Care
    • Connectivity
    • Diabetes Care
      • Biosen
      • Quo-Lab A1c
      • Quo-Test A1c
      • STAT-Site WB
    • Hematology
      • DiaSpect Tm
      • DiaSpect T
      • Hemo Control
      • HemataStat II
    • Maternal & Women's Health
      • Creamatocrit Plus
      • Pregnancy Tests
    • Sports Performance
      • Biosen - Sports
      • Lactate Scout 4
  • Central Laboratory
    • Clinical Chemistry
      • All Chemistry
      • Beta-Hydroxybutyrate
      • Glycated Albumin
      • Glycated Serum Protein
      • Nitro-tab
      • Procalcitonin
    • Immunoassay
    • Infectious Diseases
      • QuStick Strep A
    • Laboratory Analyzers
      • Altair 240
      • Biosen R-Line
      • Excel
    • Micro Centrifuges
    • Occult Blood
    • Urinalysis
  • Life Sciences
    • Contract Fermentation
    • Life Sciences OEM
    • Custom Bioprocessing
    • Diagnostic Enzymes
  • Lab Services
  • Contract Manufacturing
    • PrimeStore MTM
    • PrimeStore MTM Kit
    • COVID-SeroKlir
  • Investors
    • Announcements
    • Corporate Governance & Committees
    • Company information
    • Directors & Advisors
    • Documents & Reports
Investors : Announcements : 2021 : Investors : Investor announcements : 2021

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF to highlight specific glycemic control marker at AACC 2022

EKF Diagnostics exhibiting range of tests and analyzers on Booth #3637

EKF launches middleware connectivity solution for POC analyzers and data management

New EKF Link flexible, open solution can be securely interfaced to any vendor’s POC analyzers

EKF wins twice at the 2021 Small Cap Awards

EKF Diagnostics wins two awards at the Small Cap Awards in London.

EKF Diagnostics acquires ADL Health molecular diagnostic testing laboratory

New testing capacity complements EKF’s test kit manufacturing and point-of-care diagnostic instrument business

EKF Diagnostics to showcase at Medica 2021 STAT-Site® WB β-ketone and glucose handheld analyzer live & in person

EKF Diagnostics will be exhibiting live & in person at Medica (Hall 3 Stand B71) for the first time in mainland Europe in two years.

Product showcase

Newsletter

Keep up to date  with all our activities, events, exhibitions, promotions, investor news & more.

How this information is used

  • Your data will not be shared with third parties
  • You will only be contacted via the channels you have opted in to
  • Your data will only be stored for these purposes

Copyright © 2022 | Powered by Intergage

Quick links

News and Events

Anemia and Hemoglobin testing

Diabetes and HbA1c testing

Peer Group QC 

Support

Site Map

Remote Support

Contact Us

Support Centre

 

Social media

LinkedIn

Twitter

Facebook

YouTube

 

EKF Diagnostics - web 50px

 

Please note: Not all products are available in all countries. Please check availability.

Privacy | Terms & Conditions | Terms of Sale | UK Modern Slavery Act